DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases

Area of Science:

• Immunogenetics
• Molecular genetics
• Human disease genetics

Background:

• The DQCAR microsatellite is a polymorphic marker located between HLA DQA1 and DQB1 genes.
• Specific DQCAR alleles are linked to known HLA DR-DQ haplotypes, with longer alleles showing greater polymorphism.
• Longer DQCAR alleles can be found even within haplotypes sharing identical flanking DQA1 and DQB1 alleles.

Purpose of the Study:

• To investigate if DQCAR microsatellite typing can differentiate haplotypes with identical DRB1, DQA1, and DQB1 alleles in individuals with and without specific HLA class II associated diseases.
• To assess the utility of DQCAR typing as a supplementary marker for disease susceptibility in celiac disease, type 1 diabetes, and idiopathic nephrotic syndrome.

Main Methods:

• Comparison of DQCAR alleles in patients and matched controls carrying specific HLA DR-DQ susceptibility haplotypes.
• Inclusion of Norwegian celiac disease patients (DRB1*0301, DQA1*05011, DQB1*02), Japanese type 1 diabetes patients (DRB1*0405, DQA1*0302, DQB1*0401), and French idiopathic nephrotic syndrome patients (DRB1*0701, DQA1*0201, DQB1*0202).
• Selection of haplotypes with both short (DQCAR99) and long (DQCAR > 111) DQCAR alleles to evaluate DQCAR diversity.

Main Results:

• Additional DQCAR diversity was identified in both control and patient groups, particularly in haplotypes with long CA repeat alleles.
• DQCAR typing did not enhance the specificity of high-resolution DNA HLA typing for the studied HLA class II associated diseases.
• The DQCAR microsatellite showed increased polymorphism within haplotypes carrying long CA repeat alleles.

Conclusions:

• DQCAR typing, when combined with high-resolution DNA HLA typing, does not improve diagnostic specificity for the investigated HLA class II associated diseases.
• The DQCAR microsatellite exhibits significant polymorphism, especially in longer repeat alleles, but this does not translate to improved disease marker specificity.
• Further research may be needed to explore the role of DQCAR in other genetic contexts or diseases.